Vertex Pharmaceuticals Incorporated
H-1B· Fiscal year 2026
Median H-1B salary
$134.3K
Middle 50% range
$118.4K – $155.1K
H-1B filings
164
Salary by experience level
Entry (I) · n=4$84.9K
Qualified (II) · n=45$106.9K
Experienced (III) · n=25$128.8K
Fully competent (IV) · n=89$152.0K
Salary by role
| Role | Median H-1B salary | n |
|---|---|---|
| Business Engagement & Technology Principal Analyst | $151.8K | 7 |
| Business Engagement & Technology Senior Principal Analyst | $164.4K | 5 |
| Principal Statistical Programmer | $149.2K | 5 |
| Senior Biostatistician II | $132.2K | 5 |
| Business Engagement & Technology Principal Engineer | $161.8K | 4 |
| Commercial Analytics Senior Manager | $161.8K | 4 |
| GMP Operational Quality Senior Manager | $138.3K | 4 |
| Senior Statistical Programmer II | $129.6K | 4 |
| Process Dev Engineering Senior Scientist | $128.8K | 4 |
| Commercial Analytics Associate Director | $161.8K | 3 |
Based on certified H-1B Labor Condition Applications (offered salaries of foreign workers). Not total compensation; stock and bonus are excluded.
Estimated take-home of this pay:$8.6K / month(Federal tax only — state and local taxes are not included)Calculate →
Quick read
- Average pay is 17% above the median of the companies we track.
- Ranks #364 of 1384 Services & Education companies in this country by pay.
- Revenue grew 8.9% year over year.
- Revenue has grown two years in a row.
- Operating margin was 34.8% in 2025.
- Operating loss of $232.9M in 2024.
- Senior (level IV) H-1B pay is 1.8× entry level (level I).
Last 3 years
Revenue
Operating income
Investor metrics
2025
- Operating margin
- 34.8%
- Net margin
- 32.9%
- ROE
- 21.2%
- Debt-to-equity
- 37.4%
- Equity ratio
- 72.8%